Truscreen Group (ASX:TRU) FCF Margin %: -201.95% (As of Mar. 2025)


What is Truscreen Group FCF Margin %?

Truscreen Group ASX:TRU FCF Margin % is -201.95% as of Mar. 2025. The stock has 6 warning signs investors should review. Among 815 Medical Devices & Instruments companies, Truscreen Group ranks worse than 85.77% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Truscreen Group's Free Cash Flow for the six months ended in Mar. 2025 was A$-1.24 Mil. Truscreen Group's Revenue for the six months ended in Mar. 2025 was A$0.62 Mil. Therefore, Truscreen Group's FCF Margin % for the quarter that ended in Mar. 2025 was -201.95%.

As of today, Truscreen Group's current FCF Yield % is -14.10%.

The historical rank and industry rank for Truscreen Group's FCF Margin % or its related term are showing as below:

ASX:TRU' s FCF Margin % Range Over the Past 10 Years
Min: -465.64   Med: -143.01   Max: -96.44
Current: -133.46

During the past 12 years, the highest FCF Margin % of Truscreen Group was -96.44%. The lowest was -465.64%. And the median was -143.01%.

ASX:TRU's FCF Margin % is ranked worse than
85.77% of 815 companies
in the Medical Devices & Instruments industry
Industry Median: -0.03 vs ASX:TRU: -133.46

Truscreen Group FCF Margin % Related Terms

Truscreen Group FCF Margin % Historical Data

* Premium members only.

The historical data trend for Truscreen Group's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Truscreen Group FCF Margin % Chart

Truscreen Group Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
FCF Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -151.06 -134.93 -96.47 -133.74 -101.53

Truscreen Group Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Mar26
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -142.24 -56.24 -89.05 -201.95 0.00

ASX:TRU vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Truscreen Group's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Truscreen Group FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Truscreen Group's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Truscreen Group's FCF Margin % falls into.


Truscreen Group FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Truscreen Group's FCF Margin for the fiscal year that ended in Mar. 2026 is calculated as

FCF Margin=Free Cash Flow (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=-2.059/2.028
=-101.53 %

Truscreen Group's FCF Margin for the quarter that ended in Mar. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Mar. 2025 )/Revenue (Q: Mar. 2025 )
=-1.244/0.616
=-201.95 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -201.95% mean?
Truscreen Group (ASX:TRU) has a FCF Margin % of -201.95% as of Mar. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Truscreen Group and its competitors. According to the industry distribution chart, Truscreen Group ranks #699 out of 815 companies in the Medical Devices & Instruments industry, placing it in the top 85.8%.
Is Truscreen Group's FCF Margin % too high?
Truscreen Group's current FCF Margin % is -201.95%. Based on the distribution chart, Truscreen Group ranks #699 out of 815 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers.
How does Truscreen Group's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Truscreen Group ranks #699 out of 815 companies for FCF Margin %. This places Truscreen Group in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Truscreen Group and its competitors. Truscreen Group's current FCF Margin % is -201.95%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Truscreen Group stock overvalued right now?
Based on GuruFocus' analysis, Truscreen Group (ASX:TRU) is currently considered Significantly Overvalued. The stock's GF Value™ is A$0.01, compared to a current price of A$0.01 — trading 40% above its estimated fair value. The current FCF Margin % is -201.95%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Truscreen Group (ASX:TRU), the current FCF Margin % is -201.95% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Truscreen Group Business Description

Other Exchanges TRU:New Zealand
Address C/- HLB Mann Judd Limited, 57 Symonds Street, Level 6, Equitable House, Grafton, Auckland, NZL, 1010
Truscreen Group Ltd is a medical device company. The company manufactures and distributes the Truscreen Cervical Cancer screening device, which comprises a medical device and process designed to detect the presence in real-time of precancerous and cancerous tissue on the cervix. The product utilizes technology to detect the pre-cancerous change, or cervical intraepithelial neoplasia (CIN), by optical and electrical measurements of cervical tissue. Geographically, the company operates its business in New Zealand, Mexico, China, Russia, Zimbabwe, Vietnam, and other countries. Maximum revenue is generated from China.